Virtual Investor Event
Join Hansa Biopharma for an investor event featuring two KOLs discussing unmet need and current treatment landscape for Guillain-Barré syndrome (GBS).
June 16, 14:00 CEST/8:00 AM ET
Register and attendHansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, Sweden, will hold its Annual General Meeting on Wednesday June 25, 2025 at 14:30 CEST, Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund. Registration starts at 14:00 CEST.
Information about the Annual General Meeting and the forms for its implementation will be provided in the notice convening the Annual General Meeting.
Shareholders are entitled to have a matter dealt with at the Annual General Meeting provided that a request therefor has reached the Board of Directors no later than on 15 April 2025. The request shall be addressed to the Board of Directors but be sent to:
Hansa Biopharma AB
Attn: General Counsel
Box 785
SE-220 07 Lund, Sweden